Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.1%

2 terminated/withdrawn out of 28 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 20 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT04364503Enrolling By Invitation

Compliant Analysis of Patient Samples and Data

Role: lead

NCT07543757Recruiting

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

Role: lead

NCT03631225Completed

The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis

Role: lead

NCT06643741Recruiting

Non-Invasive Preeclampsia Screening and Biobank

Role: lead

NCT06008457Completed

Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit

Role: lead

NCT04595201Recruiting

Clinical Follow-up of Pregnant Subjects Undergoing NIPT

Role: lead

NCT01429389Recruiting

Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

Role: lead

NCT02586389Recruiting

Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

Role: lead

NCT03810144Completed

Impact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood Test

Role: lead

NCT04774640Terminated

Development of a NIPTT for Detecting Copy Number Variations

Role: lead

NCT01052688Completed

Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies

Role: lead

NCT02578264Completed

Molecular Stethoscope

Role: collaborator

NCT01555346Completed

Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies

Role: lead

NCT01597063Completed

Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies

Role: lead

NCT01880788Completed

Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD

Role: lead

NCT02226315Terminated

Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies

Role: lead

NCT00877292Completed

A New Prenatal Blood Test for Down Syndrome

Role: collaborator

NCT01682382Completed

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Role: lead

NCT01835483Completed

Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test

Role: lead

NCT01650948Completed

Genetic Load and Phenotype in Aggressive AMD

Role: lead